Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 2.543\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. CCCN(CCC)CC(O)COc1ccc([N+](=O)[O-])cc1
b. CS(=O)(=O)c1ccc(Cl)c(NC(=O)c2cccc(Br)c2)c1
c. Cc1ccc(S(=O)(=O)N2CCN(C(=O)c3ccc(N4CCCCC4)c([N+](=O)[O-])c3)CC2)cc1
d. CCCCOC(=O)C(NC(=O)c1ccccc1)=C(C)C
e. CCCS(=O)(=O)N1CCN(CCN2C(=O)c3cccc4cccc(c34)C2=O)CC1
Answer: b. CS(=O)(=O)c1ccc(Cl)c(NC(=O)c2cccc(Br)c2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CS(=O)(=O)c1ccc(Cl)c(NC(=O)c2cccc(Br)c2)c1
CS(=O)(=O)c1ccc(Cl)c(NC(=O)c2cccc(Br)c2)c1
3-bromo-N-(2-chloro-5-methylsulfonylphenyl)benzamide